Market participants will be closely following the financial results of Tenet Healthcare in its upcoming release. The company plans to announce its earnings on July 24, 2024. The company is forecasted to report an EPS of $1.89, showcasing a 31.25% upward movement from the corresponding quarter of the prior year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $4.98 billion, down 2.03% from the yearago period. Additionally, investors should keep an eye on any recent revisions to ...

Core Viewpoint - Tenet Healthcare Corporation (THC) is expected to report strong second-quarter earnings, with a consensus estimate of $1.89 per share, reflecting a 31.3% year-over-year growth, despite a slight decline in revenues [1][3]. Financial Performance - The Zacks Consensus Estimate for second-quarter revenues is nearly $5 billion, indicating a 2% decrease from the previous year [1]. - The adjusted patient admissions are projected to grow by 1.3% year-over-year, supported by the resumption of elective procedures [2][9]. - The Ambulatory Care segment is anticipated to show significant growth, with operating revenues expected to rise by 10.1% to 11.7% compared to the prior year [7]. Earnings Expectations - THC has a positive Earnings ESP of +4.11%, with the most accurate estimate at $1.97 per share, suggesting a likely earnings beat [5]. - The company has a strong track record of exceeding earnings estimates, achieving an average beat of 56.5% over the last four quarters [4]. Operational Insights - The average length of stay in hospitals is expected to increase by 3.4%, contributing to higher patient days, which are projected to rise by 5% year-over-year [8][9]. - The consensus estimate for net patient revenues per adjusted admission indicates nearly 6% growth year-over-year [8]. Strategic Direction - Tenet Healthcare is focusing on divesting non-core businesses and reallocating capital to high-margin operations, particularly in acute surgery and the Ambulatory Care segment [18][21]. - The company is actively acquiring assets to enhance profitability and is well-positioned to benefit from an aging population and increasing admissions [18][21]. Market Performance - THC's stock has increased by 74.3% year-to-date, significantly outperforming the industry average of 19.6% and the S&P 500's 15% growth [16]. - The current valuation of THC is slightly above the industry average, trading at 15.04X forward 12-month earnings compared to the industry's 14.51X [17].

THC's full-year Zacks Consensus Estimates are calling for earnings of $8.70 per share and revenue of $20.35 billion. These results would represent year-over-year changes of +24.64% and -0.95%, respectively. The most recent trading session ended with Tenet Healthcare (THC) standing at $131.75, reflecting a -1.26% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's daily loss of 0.78%. Elsewhere, the Dow lost 1.29%, while the tech-heavy Nasdaq lost 0.7%. Analysts and ...

Tenet Healthcare (THC) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Shares of this hospital operator have returned -3% over the past month versus the Zacks S&P 500 composite's +2.1% change. The Zacks Medical - Hospital industry, to which Tenet belongs, has lost 3.5% over this period. Now the key question is: Where could the stock be headed in the near term? Whi ...

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 24. On the other hand, if they miss, the stock may move lower. Zacks Consensus Estimate Revenues are expected to be $4.98 billion, down 2% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 2.62% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassesse ...

The latest trading session saw Tenet Healthcare (THC) ending at $134.39, denoting a +0.49% adjustment from its last day's close. The stock lagged the S&P 500's daily gain of 0.55%. Elsewhere, the Dow gained 0.62%, while the tech-heavy Nasdaq added 0.63%. The upcoming earnings release of Tenet Healthcare will be of great interest to investors. The company's earnings report is expected on July 24, 2024. The company's earnings per share (EPS) are projected to be $1.84, reflecting a 27.78% increase from the sam ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. What are the Zacks Style Scores? The Style Scores are broken down into four categories: Growth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and histori ...

Adding to the bullish theme, it's never been easier to find these winners, with the power of the Zacks Rank literally right at your fingertips. This system harnesses the power of the Zacks Rank, meaning that the top-ranked industries contain more stocks that are receiving upward earnings estimate revisions. Simply put, your most profitable stocks will be those with upward earnings estimate revisions in the industries enjoying the same. Image Source: Zacks Investment Research Once the top industry groups are ...

Company Overview - Tenet Healthcare's stock has increased by 2.38% over the past month, outperforming the Medical sector's gain of 0.61% but underperforming the S&P 500's gain of 2.73% [1] - The stock closed at $136.03, showing a +1.33% change from the previous day's closing price, while the S&P 500 declined by 0.31% on the same day [5] Financial Performance - For the full year, Zacks Consensus Estimates project earnings of $8.74 per share and revenue of $20.34 billion, reflecting changes of +25.21% and -1.04% respectively from the previous year [6] - The upcoming earnings release is scheduled for July 24, 2024, with an anticipated EPS of $1.83, indicating a 27.08% increase compared to the same quarter last year, while revenue is expected to be $4.98 billion, down 2.03% from the prior year quarter [9] Valuation Metrics - Tenet Healthcare is currently trading at a Forward P/E ratio of 15.35, which is lower than the industry average Forward P/E of 15.78, indicating a discount relative to its peers [3] - The company has a PEG ratio of 1.36, compared to the industry average PEG ratio of 1.47, suggesting a favorable valuation in terms of growth expectations [11] Analyst Sentiment - Recent revisions to analyst forecasts for Tenet Healthcare indicate a favorable outlook on the company's business health and profitability, with the consensus EPS projection having increased by 0.14% in the past 30 days [2][10] - Tenet Healthcare holds a Zacks Rank of 1 (Strong Buy), which has historically outperformed with an average annual return of +25% since 1988 [7] Industry Context - The Medical - Hospital industry, which includes Tenet Healthcare, has a Zacks Industry Rank of 30, placing it in the top 12% of over 250 industries [8]

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the marke ...